Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Oncocyte Corporation (Note: The input metadata references "Insight Molecular Diagnostics Inc.", but the filing text explicitly identifies the registrant as Oncocyte Corporation) on June 23, 2023. The meeting was conducted virtually. Shareholders representing 77.62% of the voting power (127,773,283 shares) were present or represented by proxy.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and shareholder voting results. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes and Voting Results
The filing details the outcomes of three shareholder proposals:
- Election of Directors: All five nominees (Joshua Riggs, Andrew Arno, Alfred D. Kingsley, Andrew J. Last, and Louis E. Silverman) were elected. While all received majority support, Alfred D. Kingsley received the lowest "For" vote count (78,869,742) compared to the others, with 5,527,521 votes withheld.
- Ratification of Auditors: Shareholders ratified the appointment of WithumSmith+Brown, PC as the independent registered public accountants for the fiscal year ending December 31, 2023. The vote was 126,399,465 For vs. 714,459 Against.
- Executive Compensation (Say-on-Pay): Shareholders approved, on a non-binding advisory basis, the named executive officer compensation for fiscal 2022. The vote was 78,956,918 For vs. 5,312,531 Against.
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of voting results.
Key Facts for Investor Verification
- Verify the correct registrant name: The filing is for Oncocyte Corporation, not Insight Molecular Diagnostics Inc.
- Review the voting split for Director Alfred D. Kingsley, who received a significantly higher number of "Withheld" votes compared to other nominees.
- Confirm the ratification of WithumSmith+Brown, PC as the auditor for the 2023 fiscal year.
- Note that the "Say-on-Pay" vote for 2022 executive compensation passed, but with a notable minority of votes cast against (approximately 6.3% of votes cast).